A meta-analysis of 1843 HCC patients across 13 studies demonstrated PD-L1 positivity correlated with shorter overall survival (HR = 1.57) and poorer DFS (HR = 2.07), particularly in advanced Barcelona Clinical Liver Cancer (BCLC) stages [134]. The gene discussed is CD274; the disease is hepatocellular carcinoma.